Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05877404 · ClinicalTrials.gov registry record
Practice Patterns Among Gynecologic Oncologists on Tumor Genetic Testing in Endometrial Cancer
A clinical trial, sponsored by Wake Forest University Health Sciences.
- Terminated
- Registry status
- 112
- Enrollment target
NCT05877404 is a clinical trial that was terminated before completion, run by Wake Forest University Health Sciences. The registered enrollment target is 112 participants.
The verdict
NCT05877404 was terminated before completion, sponsored by Wake Forest University Health Sciences.
- TERMINATED
- Registry status
- 112 participants
- Enrollment target
Study Summary
In order to formulate strategies to improve adherence to best practice guidelines, as well as utilization of novel therapies, investigators must understand current practice patterns surrounding tumor genetic testing in endometrial cancer. The aim is to survey a representative sample of gynecologic oncologists who belong to the society of gynecologic oncology, via an email survey, to better understand current practices surrounding tumor genetic testing as well as determine if there have been any changes to practice since the publication of recent trials on the use of immune-checkpoint inhibitors in endometrial cancer.
Interventions
- OTHER Surveys
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 112 participants |
| Start Date | 2023-08-15 |
| Est. Completion | 2024-02-28 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05877404
The ClinicalTrials.gov registry entry for NCT05877404 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 112 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wake Forest University Health Sciences, which has 1,140 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Surveys is the first listed.
NCT05877404 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05877404 about?
NCT05877404 is a clinical study titled "Practice Patterns Among Gynecologic Oncologists on Tumor Genetic Testing in Endometrial Cancer". In order to formulate strategies to improve adherence to best practice guidelines, as well as utilization of novel therapies, investigators must understand current practice patterns surrounding tumor genetic testing in endometrial cancer. The aim is to survey a representative sample of gynecologic o...
What is the current status of trial NCT05877404?
This trial is currently terminated. The enrollment target is 112 participants. The study started on 2023-08-15. Estimated completion is 2024-02-28.
What interventions are being tested in trial NCT05877404?
The interventions under investigation include: Surveys (OTHER).
Who is sponsoring clinical trial NCT05877404?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.